TrialCancer2025

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.

Jibran Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.